Incepta Vaccine
Dhaka, Bangladesh· Est.
Bangladesh’s pioneering WHO‑GMP‑compliant vaccine maker delivering affordable, locally produced immunizations.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Bangladesh’s pioneering WHO‑GMP‑compliant vaccine maker delivering affordable, locally produced immunizations.
Infectious Diseases
Technology Platform
Traditional inactivated vaccine production using WHO‑GMP compliant processes, with antigen adsorption onto aluminum phosphate adjuvant.
Opportunities
Growing demand for affordable, locally produced vaccines in South Asia and potential export markets, leveraging WHO‑GMP compliance and a robust cold‑chain infrastructure.
Risk Factors
Regulatory approval timelines, competition from larger multinational vaccine manufacturers, and reliance on government procurement policies.
Competitive Landscape
Competes with regional players such as Bharat Biotech, Serum Institute of India, and other emerging vaccine manufacturers, differentiating through local strain adaptation and cost‑effective production.